DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,804 | -2.0% | 7,272 | -5.2% | 0.22% | +3.8% |
| Q2 2023 | $1,840 | -38.4% | 7,667 | -35.3% | 0.21% | -40.7% |
| Q1 2023 | $2,987 | -15.1% | 11,852 | -10.6% | 0.35% | -20.9% |
| Q4 2022 | $3,517 | -99.9% | 13,252 | -0.2% | 0.44% | -1.8% |
| Q3 2022 | $3,429,000 | +1.7% | 13,277 | -0.2% | 0.45% | +10.0% |
| Q2 2022 | $3,372,000 | -47.0% | 13,302 | -38.7% | 0.41% | -35.8% |
| Q1 2022 | $6,361,000 | -29.7% | 21,684 | -21.1% | 0.64% | -24.4% |
| Q4 2021 | $9,043,000 | -2.0% | 27,484 | -9.3% | 0.85% | -10.6% |
| Q3 2021 | $9,227,000 | -7.6% | 30,309 | -18.5% | 0.95% | -6.9% |
| Q2 2021 | $9,982,000 | +18.0% | 37,195 | -1.0% | 1.02% | +8.1% |
| Q1 2021 | $8,460,000 | -0.2% | 37,585 | -1.5% | 0.94% | -6.4% |
| Q4 2020 | $8,475,000 | -3.8% | 38,150 | -6.8% | 1.00% | -16.3% |
| Q3 2020 | $8,811,000 | +21.8% | 40,920 | 0.0% | 1.20% | +7.3% |
| Q2 2020 | $7,236,000 | +27.7% | 40,920 | -0.1% | 1.12% | +3.3% |
| Q1 2020 | $5,667,000 | -9.8% | 40,945 | 0.0% | 1.08% | +15.2% |
| Q4 2019 | $6,284,000 | +6.3% | 40,945 | 0.0% | 0.94% | -4.0% |
| Q3 2019 | $5,914,000 | -3.6% | 40,945 | -4.7% | 0.98% | -5.0% |
| Q2 2019 | $6,138,000 | -18.6% | 42,945 | -24.8% | 1.03% | -15.2% |
| Q1 2019 | $7,544,000 | +28.0% | 57,145 | 0.0% | 1.22% | +13.0% |
| Q4 2018 | $5,893,000 | -5.1% | 57,145 | 0.0% | 1.08% | +15.0% |
| Q3 2018 | $6,209,000 | +10.1% | 57,145 | 0.0% | 0.94% | +0.3% |
| Q2 2018 | $5,639,000 | +0.4% | 57,145 | -0.4% | 0.93% | -1.1% |
| Q1 2018 | $5,619,000 | +5.5% | 57,385 | 0.0% | 0.94% | +6.7% |
| Q4 2017 | $5,326,000 | +8.2% | 57,385 | 0.0% | 0.88% | +2.0% |
| Q3 2017 | $4,922,000 | -0.4% | 57,385 | -2.0% | 0.87% | -3.9% |
| Q2 2017 | $4,940,000 | -1.2% | 58,535 | +0.1% | 0.90% | -3.1% |
| Q1 2017 | $5,000,000 | +7.8% | 58,455 | -1.9% | 0.93% | +3.9% |
| Q4 2016 | $4,637,000 | -0.7% | 59,575 | 0.0% | 0.90% | +0.3% |
| Q3 2016 | $4,670,000 | -22.2% | 59,575 | +0.2% | 0.89% | -26.8% |
| Q2 2016 | $6,006,000 | +6.2% | 59,470 | -0.3% | 1.22% | +6.9% |
| Q1 2016 | $5,658,000 | +2.0% | 59,650 | -0.1% | 1.14% | +3.0% |
| Q4 2015 | $5,545,000 | +8.6% | 59,700 | -0.4% | 1.11% | +4.3% |
| Q3 2015 | $5,108,000 | -3.9% | 59,950 | -3.5% | 1.06% | +7.1% |
| Q2 2015 | $5,317,000 | +0.2% | 62,120 | -0.6% | 0.99% | +1.2% |
| Q1 2015 | $5,308,000 | -5.8% | 62,520 | -4.9% | 0.98% | -8.5% |
| Q4 2014 | $5,637,000 | +12.8% | 65,770 | 0.0% | 1.07% | +11.8% |
| Q3 2014 | $4,997,000 | -5.0% | 65,770 | -1.6% | 0.96% | -2.0% |
| Q2 2014 | $5,260,000 | -1.4% | 66,810 | -6.1% | 0.98% | -5.6% |
| Q1 2014 | $5,336,000 | -2.1% | 71,150 | +0.8% | 1.03% | -2.8% |
| Q4 2013 | $5,450,000 | +9.7% | 70,600 | -1.5% | 1.06% | +0.3% |
| Q3 2013 | $4,970,000 | +9.6% | 71,700 | +0.1% | 1.06% | +2.0% |
| Q2 2013 | $4,535,000 | – | 71,650 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |